Onderzoeker
Mourad Gumusboga
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf1 jan 2003 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 2002 → 16 apr 2015
Projecten
1 - 2 of 2
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
- Institutional strengthening of the Mycobacteria Reference Laboratory (LRM, Bénin) for quality services and better quality of health care for Mycobacteria and other clinical bacteria, at National and Regional Level.Vanaf1 jan 2018 → 31 dec 2018
Publicaties
11 - 20 van 22
- Specific gyrA gene mutations predict poor treatment outcome in MDR-TB(2016)
Auteurs: L Rigouts, Nele Coeck, M Gumusboga, P De Rijk, K.J.M. Aung, M.A. Hossain, K Fissette, H L Rieder, Conor J. Meehan, Bouke de Jong, et al.
Pagina's: 314-323 - Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients(2015)
Auteurs: A Van Deun, K.J.M. Aung, A Hossain, P De Rijk, M Gumusboga, L Rigouts, Bouke de Jong
Pagina's: 185-190 - An operational study comparing microscopes and staining variations for tuberculosis LED FM(2014)
Auteurs: Armand Van Deun, K.J.M. Aung, M H Khan, Bouke de Jong, M Gumusboga, M.A. Hossain
Pagina's: 964-971 - Rifampicin drug resistance tests for tuberculosis: challenging the gold standard(2013)
Auteurs: Armand Van Deun, A.K. Maug, V Bola, R. Lebeke, M.A. Hossain, P De Rijk, L Rigouts, M Gumusboga, Gabriela Torrea, Bouke de Jong
Pagina's: 2633-2640 - Rifampicin resistance missed in automated liquid culture system for Mycobacterium tuberculosis with specific rpoB-mutations(2013)
Auteurs: L Rigouts, M Gumusboga, P De Rijk, E Nduwamahoro, C Uwizeye, Bouke de Jong, Armand Van Deun
Pagina's: 2641-2645 - Resistance of Mycobacterium tuberculosis to first and second line anti tuberculosis drugs in south west, Nigeria(2012)
Auteurs: E Osman, O. Daniel, S. Ogiri, A Awe, O. Obasanya, E. Adebiyi, O. Ige, O. Oladimeji, O.G. Dairo, E Declercq, et al.
- Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis(2012)
Auteurs: Armand Van Deun, A.K.J. Maug, A Hossain, M Gumusboga, Bouke de Jong
Pagina's: 1174-1179 - Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout(2012)
Auteurs: KJM Aung, E Declercq, AM Ali, S Naha, SC Datta Roy, MA Taleb, MA Hossain, L Rigouts, M Gumusboga, A Van Deun
Pagina's: 455-461 - Ofloxacin resistance among Mycobacterium tuberculosis isolates in two states of south-west Nigeria(2011)
Auteurs: O. Daniel, E Osman, R Bakare, P Adebiyi, O. Ige, S. Ogiri, A Awe, M Kabir, O Ogundaunsi, Mourad Gumusboga, et al.
Pagina's: 18-20 - Methylene blue is a good background stain for tuberculosis light-emitting diode fluorescence microscopy(2010)
Auteurs: A Van Deun, KJ Aung, A Hamid Salim, M Gumusboga, P Nandi, MA Hossain
Pagina's: 1571-1575